Glenmark Pharmaceuticals Ltd. · Q3FY26
Result on 30 Jan 2026, first traded on 2 Feb 2026; judged on 15 Sep 2026. The last read before it, on 24 Jan 2026 (6 days ahead), called it favourable, rank 50 of 229 reporting; the share then stayed within 2% of the market over ten sessions. The company's page →
flat / no callverdict
favourablethe read
-0.7%vs market, 10 sessions
-3.1%T+1
1 · What the read said
morning of 24 Jan- Read
- favourable — rank 50 of 229 reporting that week
- Composite
- 65.9 out of 100
- Evidence
- full · 14 results on record
- Expected move
- ±4.8% on the day — its average absolute move on results
- Habit
- reversal — the day-one move usually reverses over the following sessions
- Close that morning
- ₹1,967.70
Reactivity · 30%
69
Momentum · 20%
83
vs market · 30%
78
vs sector · 20%
26
Each layer is a percentile among that week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 69.0 + 0.20 × 83.5 + 0.30 × 77.6 + 0.20 × 26.2 = 65.9
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹2,015.90the base every move below is measured from
T+1-3.1%a real move — at least 60% of its usual
T+10+0.7%market +1.4% · sector +3.2%
vs market-0.7%vs sector -2.4%
Best close after+0.9%traded as high as +1.6% on 13 Feb
Worst close after-4.7%traded as low as -8.6% on 2 Feb
Run-up, 30 sessions+3.5%into the result
52-week range9% below high58% above low
- Delivery share
- +0.6 points in the fortnight before, against the month before that
- Volume
- 0.73× its prior month, in the fortnight before
- Habit held
- reversal — held this quarter
- Announced
- Mon, timing unknown
- Peers reporting
- 3 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Its reversal habit held this quarter.
- 3 sector peers reported the same week; the sector read may already have been set.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
1 mornings| Morning | Days ahead | Read | Rank | Comp. | L1 | L2 | L3 | L4 | Close | Note |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Jan judged simulated | 6 | favourable | 50/229 | 65.9 | 69 | 83 | 78 | 26 | ₹1,967.70 |
A read is made each morning the company is due within seven days. The highlighted morning is the last one before the result — the read this post-mortem judges. Excluded mornings show why the name dropped out that day.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-27 | 19 Dec | 1,960.00 | 1,996.20 | 1,952.60 | 1,992.10 | — | -1.18% | +2.55% | +4.77% |
| T-26 | 22 Dec | 1,997.90 | 2,042.70 | 1,992.10 | 2,038.20 | +2.31% | +1.11% | +3.36% | +5.59% |
| T-25 | 23 Dec | 2,041.00 | 2,082.50 | 2,036.50 | 2,047.00 | +0.43% | +1.54% | +3.38% | +5.34% |
| T-24 | 24 Dec | 2,050.00 | 2,054.90 | 2,013.80 | 2,020.10 | -1.31% | +0.21% | +3.24% | +4.80% |
| T-23 | 26 Dec | 2,018.00 | 2,025.90 | 2,004.30 | 2,010.60 | -0.47% | -0.26% | +2.85% | +4.46% |
| T-22 | 29 Dec | 2,012.00 | 2,028.50 | 2,000.40 | 2,009.70 | -0.04% | -0.31% | +2.45% | +3.98% |
| T-21 | 30 Dec | 2,004.60 | 2,039.00 | 2,000.00 | 2,029.80 | +1.00% | +0.69% | +2.44% | +3.80% |
| T-20 | 31 Dec | 2,030.90 | 2,048.40 | 2,025.70 | 2,035.20 | +0.27% | +0.96% | +3.19% | +4.64% |
| T-19 | 1 Jan | 2,034.00 | 2,039.10 | 2,011.00 | 2,026.20 | -0.44% | +0.51% | +3.26% | +4.23% |
| T-18 | 2 Jan | 2,025.90 | 2,073.00 | 2,021.00 | 2,064.50 | +1.89% | +2.41% | +3.98% | +4.95% |
| T-17 | 5 Jan | 2,071.50 | 2,091.80 | 2,031.50 | 2,039.20 | -1.23% | +1.16% | +3.67% | +4.74% |
| T-16 | 6 Jan | 2,031.50 | 2,080.80 | 2,031.50 | 2,074.60 | +1.74% | +2.91% | +3.39% | +6.50% |
| T-15 | 7 Jan | 2,076.00 | 2,147.50 | 2,070.70 | 2,113.10 | +1.86% | +4.82% | +3.24% | +7.24% |
| T-14 | 8 Jan | 2,122.10 | 2,122.10 | 2,074.00 | 2,079.80 | -1.58% | +3.17% | +2.20% | +5.74% |
| T-13 | 9 Jan | 2,074.00 | 2,079.00 | 1,997.00 | 2,007.20 | -3.49% | -0.43% | +1.43% | +4.82% |
| T-12 | 12 Jan | 2,007.20 | 2,020.40 | 1,967.60 | 2,017.50 | +0.51% | +0.08% | +1.85% | +4.39% |
| T-11 | 13 Jan | 2,028.00 | 2,028.00 | 1,951.10 | 2,008.20 | -0.46% | -0.38% | +1.63% | +3.90% |
| T-10 | 14 Jan | 2,025.00 | 2,041.80 | 2,003.30 | 2,011.30 | +0.15% | -0.23% | +1.36% | +3.64% |
| T-9 | 16 Jan | 2,022.00 | 2,028.00 | 1,990.00 | 2,000.70 | -0.53% | -0.75% | +1.48% | +2.31% |
| T-8 | 19 Jan | 1,996.00 | 2,007.40 | 1,980.30 | 1,989.80 | -0.54% | -1.29% | +1.05% | +1.94% |
| T-7 | 20 Jan | 1,980.30 | 1,989.80 | 1,927.40 | 1,935.00 | -2.75% | -4.01% | -0.35% | -0.00% |
| T-6 | 21 Jan | 1,927.00 | 1,960.00 | 1,910.10 | 1,941.40 | +0.33% | -3.70% | -0.64% | -0.60% |
| T-5 | 22 Jan | 1,955.00 | 2,009.00 | 1,955.00 | 1,997.20 | +2.87% | -0.93% | -0.12% | +0.98% |
| T-4 | 23 Jan | 2,000.00 | 2,022.90 | 1,961.80 | 1,967.70 | -1.48% | -2.39% | -1.07% | +0.03% |
| T-3 | 27 Jan | 1,968.40 | 2,010.00 | 1,967.10 | 1,999.70 | +1.63% | -0.80% | -0.57% | +0.34% |
| T-2 | 28 Jan | 2,011.50 | 2,012.10 | 1,980.00 | 1,993.50 | -0.31% | -1.11% | +0.09% | +0.11% |
| T-1 | 29 Jan | 2,002.40 | 2,022.00 | 1,975.10 | 1,985.60 | -0.40% | -1.50% | +0.39% | -0.70% |
| base | 30 Jan | 1,978.70 | 2,026.10 | 1,928.80 | 2,015.90 | +1.53% | +0.00% | +0.00% | +0.00% |
| T+1 | 2 Feb result | 1,935.10 | 1,964.40 | 1,842.00 | 1,920.40 | -4.74% | -4.74% | -0.92% | -0.76% |
| T+2 | 3 Feb | 1,995.00 | 2,006.60 | 1,947.60 | 1,954.20 | +1.76% | -3.06% | +1.61% | +2.23% |
| T+3 | 4 Feb | 1,954.20 | 1,992.10 | 1,945.90 | 1,959.30 | +0.26% | -2.81% | +1.80% | +1.89% |
| T+4 | 5 Feb | 1,955.20 | 1,976.30 | 1,926.00 | 1,969.30 | +0.51% | -2.31% | +1.27% | +1.86% |
| T+5 | 6 Feb | 1,969.30 | 1,969.30 | 1,911.00 | 1,934.80 | -1.75% | -4.02% | +1.47% | +1.13% |
| T+6 | 9 Feb | 1,958.00 | 1,979.90 | 1,941.40 | 1,974.40 | +2.05% | -2.06% | +2.16% | +2.65% |
| T+7 | 10 Feb | 2,000.00 | 2,000.10 | 1,953.40 | 1,958.00 | -0.83% | -2.87% | +2.43% | +2.28% |
| T+8 | 11 Feb | 1,959.90 | 2,018.90 | 1,949.90 | 2,015.20 | +2.92% | -0.03% | +2.50% | +3.31% |
| T+9 | 12 Feb | 2,020.00 | 2,039.00 | 2,001.10 | 2,034.50 | +0.96% | +0.92% | +1.92% | +3.09% |
| T+10 | 13 Feb | 2,034.00 | 2,047.90 | 1,992.00 | 1,997.60 | -1.81% | -0.91% | +0.59% | +2.21% |
| T+11 | 16 Feb | 1,997.60 | 2,037.40 | 1,988.00 | 2,030.50 | +1.65% | +0.72% | +1.43% | +3.17% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.